You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Hematopoietic Stem Cell Transplant (AHCT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (Plinabulin)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jun 17, 2022

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)

Active, not recruiting
  • Recurrent Adult Hodgkin Lymphoma
  • basiliximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

Recruiting
  • Well-being of Caregivers (Caregiver Strain Index)
  • home care
  • Durham, North Carolina
    Duke University Medical Center
Jan 25, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation，TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

Stem Cell Trial in Houston (Enteral nutrition (EN), Standard care parenteral nutrition (PN))

Recruiting
  • Stem Cell
  • Enteral nutrition (EN)
  • Standard care parenteral nutrition (PN)
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
  • Cardio-oncology program
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 6, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Development of Liver Dysfunction in Hematopoietic Stem Cell

    Not yet recruiting
    • Hematopoietic Stem Cell Transplant
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 16, 2023

      Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

      Active, not recruiting
      • Plasma Cell Leukemia
      • +3 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 6, 2022

      Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

      Not yet recruiting
      • Transplantation, Hematopoietic Stem Cell
      • Biological samples (blood and oral fluid)
      • Lyon, France
        Hôpital de la Croix Rousse - service des maladies infectieuses e
      Jul 7, 2023

      DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

      Recruiting
      • DOCK8 Deficiency
      • Reduced-intensity hematopoietic stem cell
      • +6 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

      Not yet recruiting
      • GATA2
      • Immunodeficiency
      • Mycophenolate Mofetil
      • +7 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 23, 2023

      (LTFU) of Patients Treated With Genome-edited Autologous

      Not yet recruiting
      • Sickle Cell Disease
      • OTQ923
      • (no location specified)
      Nov 24, 2023

      Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

      Active, not recruiting
      • Plasma Cell Leukemia
      • Plasma Cell Myeloma
      • Autologous Hematopoietic Stem Cell Transplantation
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

      Not yet recruiting
      • Hematologic Malignancy
      • +5 more
      • autologous hematopoietic stem cells added to planned CAR T
      • Los Angeles, California
        Cedars-Sinai Medical Center
      May 31, 2023

      Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

      Recruiting
      • Systemic Lupus Erythematosus
      • Systemic Sclerosis
      • Depletion of CD3/CD19 in an autologous stem cell transplant
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      May 23, 2022

      ASCT Versus Chemotherapy as First-Line Consolidation Therapy

      Completed
      • T-cell Lymphoma Adults
      • consolidation with ASCT
      • (no location specified)
      Nov 25, 2023

      Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

      Not yet recruiting
      • Blood Disease
      • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
      • CliniMACS® System
      • (no location specified)
      Jan 30, 2023

      COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

      Suspended
      • COVID-19 Infection
      • +2 more
      • Questionnaire Administration
      • Sotrovimab
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 24, 2023